Sproutly Canada Inc.

OTC: SRUTF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#980 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 30

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, workforce scale · ↓ market scale, return on assets

Methodology →

Revenue TTM

$407.6k

Rev growth YoY (TTM)

+36.8%

Net income (FY)

-$12.3M

Employees

Market cap

$3.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$237.1k316.4k CAD2020

Net income-$12.3M-16.4M CAD2020

Operating income-$10.6M-14.1M CAD2020

Total assets$3.3M4.2M CAD2020

Liabilities$7.7M9.8M CAD2020

Equity-$4.4M-5.6M CAD2020

Revenue trend

FY2016 – FY2020 · USD

FY16

FY17

FY18

$699.3k

FY19

$237.1k

FY20

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Sproutly Canada Inc. booked $237.1k in FY2020 revenue, contracting 66% year over year — slower than 86% of Healthcare companies we track, at a -5186.7% net margin.

Peers · Healthcare

Regen BioPharma, Inc.37D Sienna Biopharmaceuticals, Inc.——Comera Life Sciences Holdings, Inc.——Rebus Holdings, Inc.——

Key facts

CEOArup Sen

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: SRUTF

Employees27

IPO date2018-07-10

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.